Search

everythinglearnresearchcommunity

for

Search:↓

Ficus carica extract improved fertility in rats and may help with certain health conditions.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

A Rathke's cleft cyst caused hormonal imbalances and symptoms in a 68-year-old woman.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

PCOS symptoms can improve with specific treatments for pituitary adenomas.

Subclinical hypothyroidism in women with PCOS affects thyroid and hormone interactions but not ovary structure.

Women with PCOS have different hormone levels compared to those without PCOS.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Finasteride may decrease semen quality but not harm sperm production, and stopping the drug can improve semen quality; hyperprolactinemia can cause infertility but is treatable with medication.

Women aged 21-26 have a higher rate of PCOS.

3βHSD2 is not useful for diagnosing PCOS.

Vitamin E helps reduce PCOS symptoms and improves hormonal balance.

Women with PCOS have different hormone levels than those without it.

Hormonal imbalances are important in the development of male pattern baldness.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Abuse of anabolic steroids in Iraqi athletes leads to negative effects on hormones, liver and kidney function, blood sugar, and cholesterol levels.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Human scalp hair follicles can produce and respond to several hormones, affecting hair growth and pigmentation.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hormone therapy might be a proactive alternative to watchful waiting for early-stage prostate cancer, potentially improving survival without aggressive treatment downsides.

Higher testosterone and dehydroepiandrosterone sulphate levels may help diagnose meibomian gland dysfunction.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hypothyroidism and hyperprolactinemia may cause hair loss in women.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Using neurohormones to control keratin can lead to new skin disease treatments.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Hormonal imbalances, including high prolactin and thyroid issues, contribute to hair growth problems in women.